Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
189.27%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.39Close
$ 0.68 - $ 3.23 52-Week Range
Ticker Information
Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFATE THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FATE - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 16.03M | 189.27% | $ 8.47M |
| 3/31/2025 | $ 17.47M | 131.04% | $ 13.34M |
| 12/31/2024 | $ 18.96M | 139.11% | $ 13.63M |
| 9/30/2024 | $ 19.03M | 141.55% | $ 13.45M |
| 6/30/2024 | $ 19.17M | 155.61% | $ 12.32M |
| 3/31/2024 | $ 18.91M | 291.94% | $ 6.48M |
| 12/31/2023 | $ 18.28M | 28.78% | $ 63.53M |
| 9/30/2023 | $ 18.24M | 17.17% | $ 106.21M |
| 6/30/2023 | $ 16.69M | 14% | $ 119.25M |
| 3/31/2023 | $ 15.19M | 11.1% | $ 136.87M |
Key Performance Insights, Last 5 Years
- FATE THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 15.53%.
- Over the past 5 years, FATE THERAPEUTICS INC's average DepAmor % has been 61.81%.
- The median DepAmor % for FATE THERAPEUTICS INC during this period was 14.91%
- FATE THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 291.94%.
- The lowest DepAmor % recorded by FATE THERAPEUTICS INC in the same timeframe 7.83%
FATE THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for FATE THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.85M ] / Revenues [ $ 18.34M ]
(=) DepAmor % [ 15.53% ] FATE - Depreciation and Amortization Margin, Last 5 years
7.83%
Minimum
Jun 30, 2021
291.94%
Maximum
Mar 31, 2024
61.81%
Average
14.91%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |